Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2020 $ 3 $ 95 $ 583,000 $ (482,760) $ 96,661 $ 196,999
Balance (in shares) at Dec. 31, 2020 3,427,138 94,877,492        
Stock-based compensation expense     19,486     19,486
Issuance of common stock related to equity plans   $ 3 275     278
Issuance of common stock related to equity plans (in shares)   3,236,752        
Issuance of common stock for at-the-market offering, net   $ 3 9,082     9,085
Issuance of common stock for at-the-market offering, net (in shares)   3,067,446        
Payment of Series A perpetual preferred stock dividends     (8,031)     (8,031)
Partner company's offering, net     34,996     34,996
Partner company's at-the-market offering, net     110,887     110,887
Partner company's exercise of options for cash     7     7
Issuance of common stock under partner company's ESPP     309     309
Partner company's dividends declared and paid     (749)     (749)
Common shares issued for dividend on partner company's convertible preferred shares     820     820
Common shares issued for dividend on partner company's convertible preferred shares (in shares)   253,815        
Conversion of partner company convertible preferred shares     21,812     21,812
Conversion of partner company derivative warrant liabilities     4,628     4,628
Issuance (reversal) of partner company's common shares for research and development expenses     176     176
Partner company's warrants issued in conjunction with debt           0
Partner company's retained earning adjustment           0
Non-controlling interest in subsidiaries     (120,665)   120,665  
Net loss attributable to non-controlling interest         (100,123) (100,123)
Net loss attributable to common stockholders       (64,703)   (64,703)
Balance at Dec. 31, 2021 $ 3 $ 101 656,033 (547,463) 117,203 225,877
Balance (in shares) at Dec. 31, 2021 3,427,138 101,435,505        
Stock-based compensation expense     22,987     22,987
Issuance of common stock related to equity plans   $ 5 169     174
Issuance of common stock related to equity plans (in shares)   4,913,804        
Issuance of common stock for at-the-market offering, net   $ 4 6,049     6,053
Issuance of common stock for at-the-market offering, net (in shares)   4,144,936        
Payment of Series A perpetual preferred stock dividends     (8,031)     (8,031)
Partner company's offering, net     3,205     3,205
Partner company's at-the-market offering, net     16,370     16,370
Partner company's exercise of options for cash     142     142
Partner company's exercise of warrants for cash     148     148
Partner company's reclassification of warrant liability to equity     89     89
Partner company's repurchase of stock     (1,105)     (1,105)
Issuance of common stock under partner company's ESPP     206     206
Partner company's dividends declared and paid     (749)     (749)
Partner company's redemption of preferred shares     (85)     (85)
Partner company's stock adjustment     (6)     (6)
Partner company's net settlement of shares withheld for taxes     (1,698)     (1,698)
Issuance (reversal) of partner company's common shares for research and development expenses     (23)     (23)
Partner company's warrants issued in conjunction with debt     384     384
Partner company's retained earning adjustment     195 (195)   195
Non-controlling interest in subsidiaries     (18,439)   18,439  
Net loss attributable to non-controlling interest         (127,338) (127,338)
Net loss attributable to common stockholders       (86,575)   (86,575)
Balance at Dec. 31, 2022 $ 3 $ 110 $ 675,841 $ (634,233) $ 8,304 $ 50,025
Balance (in shares) at Dec. 31, 2022 3,427,138 110,494,245